Back | Next |
home / stock / dtil / dtil message board
Subject | By | Source | When |
---|---|---|---|
$DTIL The trading | rtrstock | investorshub | 05/24/2023 9:04:26 PM |
$DTIL bears are running | rtrstock | investorshub | 05/24/2023 4:29:01 PM |
MomentumIts now last trade up | NY1972 | investorshub | 05/24/2023 12:36:45 AM |
Long and strong lets hope im right | jondoeuk | investorshub | 05/23/2023 2:30:50 PM |
MomentumIts trading last up | jondoeuk | investorshub | 05/23/2023 6:50:53 AM |
This was presented (CAR-T) https://annualmeeting.asgct.org/abstracts/abstract-de | jondoeuk | investorshub | 05/18/2023 9:34:57 PM |
Two LBAs (at ASGCT) | jondoeuk | investorshub | 05/12/2023 11:23:02 PM |
It could. Another might be the direction the | jondoeuk | investorshub | 05/11/2023 5:31:08 PM |
Here is 1 reason why CSO left. Looks | NY1972 | investorshub | 05/08/2023 11:00:15 PM |
PhDs love stock options from new bios. The | NY1972 | investorshub | 05/03/2023 7:02:02 PM |
Some of the authors have links to Tune | jondoeuk | investorshub | 05/01/2023 8:53:38 PM |
Too many high paid spoiled PhDs. Too much | NY1972 | investorshub | 04/17/2023 12:06:47 AM |
What is the future of the company? | rtrstock | investorshub | 04/15/2023 10:23:53 PM |
He has now taken up the same position | jondoeuk | investorshub | 04/13/2023 9:26:54 PM |
CSO left. Worse significant antigen expression decrease after | NY1972 | investorshub | 04/12/2023 1:32:00 AM |
Could be. Even if not, every time the | jondoeuk | investorshub | 04/11/2023 7:43:29 PM |
It will be delayed in May. CART is | NY1972 | investorshub | 04/06/2023 6:00:34 PM |
The update is now expected in May. | jondoeuk | investorshub | 04/04/2023 8:37:10 PM |
This is recent https://www.nature.com/articles/s41586-023-05787-1 | jondoeuk | investorshub | 03/18/2023 12:23:55 AM |
Have you seen any tumor biopsy studies comparing | NY1972 | investorshub | 03/16/2023 4:26:50 PM |
News, Short Squeeze, Breakout and More Instantly...
Precision BioSciences Inc. Company Name:
DTIL Stock Symbol:
NYSE Market:
Precision BioSciences Inc. Website:
Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing therapies, today announced that the company will present at the upcoming JonesTrading Healthcare Seaside Summit being held July 14...
2024-07-06 17:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, today announced its addition to the Russel...